Cover Image

Steatotic Liver Disease‐Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog‐Treated Chronic Hepatitis B

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Tyng‐Yuan Jang, Chih‐Wen Wang, Po‐Cheng Liang, Yu‐Ju Wei, Ming‐Lun Yeh, Yi‐Hung Lin, Chao‐Kuan Huang, Pei‐Chien Tsai, Yu‐Min Ko, Yi‐Shan Tsai, Kuan‐Yu Chen, Ching‐Chih Lin, Zu‐Yau Lin, Jee‐Fu Huang, Chia‐Yen Dai, Chung‐Feng Huang, Wan‐Long Chuang, Ming‐Lung Yu
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Journal of Gastroenterology and Hepatology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of Air Pollution in Development of Hepatocellular Carcinoma Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues
by: Tyng‐Yuan Jang, et al.
Published: (2024)

Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29‐year follow‐up
by: Ming‐Whei Yu, et al.
Published: (2024)

Prevalence, proportions of elevated liver enzyme levels, and long‐term cardiometabolic mortality of patients with metabolic dysfunction‐associated steatotic liver disease
by: Yi‐Ting Chen, et al.
Published: (2024)

Air Pollution Associated With Mortality Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues
by: Tyng‐Yuan Jang, et al.
Published: (2025)

Incidences of Virological and Clinical Relapses After Cessation of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Entecavir in Patients With HBeAg‐Negative Chronic Hepatitis B
by: Cheng‐Hao Tseng, et al.
Published: (2025)

Aspirin Use and Hepatocellular Carcinoma Risk
by: Kuan‐Fu Liao, et al.
Published: (2025)

Advanced Fibrosis and Cardiometabolic Risk Burden Increase Major Cardiovascular Events in Chronic Hepatitis C Patients With Steatotic Liver Disease After Viral Eradication
by: Pei‐Chien Tsai, et al.
Published: (2025)

Letter to the Editor: “Excessive Visceral Adipose Tissue Accumulation Increases the Risk of Recurrence and Mortality After Curative Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease‐Associated Hepatocellular Carcinoma”
by: Lixia Yao, et al.
Published: (2025)

Circulating let‐7 Predicts Hepatic Fibrogenesis of 12‐Month Post‐Nucleos(t)ide Analog Treatment in Patients With Hepatitis B Virus
by: Yi‐Shan Tsai, et al.
Published: (2025)

The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long‐Term Administration of Nucleos(t)ide Analogs
by: Kazuhiro Murai, et al.
Published: (2025)

Gastric neoplasm detection of computer‐aided detection‐assisted esophagogastroduodenoscopy changes with implement scenarios: a real‐world study
by: Li Huang, et al.
Published: (2024)

Air Pollution Associated With MASLD
by: Tyng‐Yuan Jang
Published: (2025)

Mediterranean Diet Adherence Is Associated With Reduced Liver Fibrosis Risk in Metabolic Dysfunction–Associated Steatotic Liver Disease
by: Meng‐Lun Hsieh, et al.
Published: (2026)

Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium‐90 resin microspheres in Taiwan: data from the RESIN registry
by: Rheun‐Chuan Lee, et al.
Published: (2024)

The Impact of Hepatitis B Virus on the Tumor Microenvironment of Hepatocellular Carcinoma and Therapeutic Strategies
by: Ximing Li, et al.
Published: (2026)

KAT8: A Promising Biomarker for the Prognosis of Hepatitis B Virus‐Related Acute‐on‐Chronic Liver Failure
by: Xiaolin Wang, et al.
Published: (2026)

Hepatitis B surface antigen loss in chronic hepatitis B patients with low‐viral‐load
by: Tyng‐Yuan Jang, et al.
Published: (2024)

Toward a Synthetic Data Revolution: Diffusion Model‐Enhanced Hepatocellular Carcinoma Prediction in Steatotic Liver Disease
by: Masaya Sato, et al.
Published: (2026)

Comment on “The Efficacy and Safety of Endoscopic Submucosal Dissection (ESD) Combined With Radiofrequency Ablation (RFA) Sequential Therapy for Extensive Esophageal Lesions”
by: Jing‐Yu Zhu, et al.
Published: (2025)

Endoscopic Mucosal Resection Using an Over‐the‐Scope Clip for Duodenal Neuroendocrine Tumors: A Promising Method
by: Yi‐Heng Yao, et al.
Published: (2025)

Increased Prevalence of Barrett's Esophagus in Taiwan: A Prospective Multicenter Study
by: Fu‐Jen Lee, et al.
Published: (2025)

Canagliflozin Alleviates Metabolic Dysfunction‐Associated Steatotic Liver Disease via Mitochondrial Protection and Enhanced Mitophagy
by: Ming Lu, et al.
Published: (2025)

The association between proton‐pump inhibitor use and recurrence of hepatocellular carcinoma after hepatectomy
by: Chun‐Ting Ho, et al.
Published: (2024)

Clinical Trial: The Optimal Timing of the Endoscope Insertion After Oral Lidocaine Spray. A Randomized Controlled Trial
by: Hsueh‐Chien Chiang, et al.
Published: (2025)

Combined Impact of Triglyceride–Glucose Index and Alanine Aminotransferase on Steatotic Liver Disease and Subtypes
by: Yu‐Jin Kwon, et al.
Published: (2026)

Refining Surgical Candidate Selection After Systemic Therapy in Advanced Hepatocellular Carcinoma
by: Jinzhen Huang, et al.
Published: (2025)

Performance of the GALAD Model in an Asian Cohort Undergoing Hepatocellular Carcinoma Surveillance: A Prospective Cohort Study
by: Wei‐Lun Liou, et al.
Published: (2025)

Gastrointestinal: Biliary Obstruction From Hepatic Artery Aneurysms: Implications for Treatment Selection
by: Derek Ngan‐Wa Wong, et al.
Published: (2024)

Feasibility and Safety of Endoscopic Full‐Thickness Resection for Gastric Submucosal Tumors With Extraluminal Growth
by: Shao‐Bin Luo, et al.
Published: (2025)

The Roles and Clinical Significance of Major Hepatic‐Derived Metabolites in Hepatocellular Carcinoma
by: Rui Sun, et al.
Published: (2025)

The impact of vedolizumab therapy on extraintestinal manifestations in patients with inflammatory bowel disease: A systematic review and meta‐analysis
by: Dian‐yu Zheng, et al.
Published: (2024)

Comment on“Anti‐MRPS27 Antibody: A Novel Diagnostic Biomarker for Autoimmune Hepatitis Identified via a Human Proteome Microarray”
by: Wei Ouyang, et al.
Published: (2026)

Regarding the “Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy”
by: Wei Huang, et al.
Published: (2024)

Cumulative Dose of Regorafenib in Patients With Metastatic Colorectal Cancer: A Multicenter Cohort Study
by: Yu‐Hsuan Kuo, et al.
Published: (2025)

PFKL Inhibition by DT‐13: A Novel Approach to Combat Hepatocellular Carcinoma
by: Qiang Yu, et al.
Published: (2025)

Machine Learning Models to Predict Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) With Simple Anthropometric and Biochemical Variables: A Cross‐Sectional Study in US Population
by: Shiying Du, et al.
Published: (2026)

HDAC9 as a Sex‐Dependent Epigenetic Driver of Hepatic Steatosis and Adipose Inflammation
by: Yu Ji Kim, et al.
Published: (2025)

Excessive Visceral Adipose Tissue Accumulation Increases the Risk of Recurrence and Mortality After Curative Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease‐Associated Hepatocellular Carcinoma
by: Kenji Imai, et al.
Published: (2025)

Response to “Excessive Visceral Adipose Tissue Accumulation Increases the Risk of Recurrence and Mortality After Curative Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease‐Associated Hepatocellular Carcinoma”
by: Kenji Imai, et al.
Published: (2026)

Two‐stage deep‐learning‐based colonoscopy polyp detection incorporating fisheye and reflection correction
by: Chen‐Ming Hsu, et al.
Published: (2024)